Detection of Asymptomatic Atrial Fibrillation in Persons of 65 Year of Age or Older
NCT ID: NCT04375241
Last Updated: 2022-07-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2168 participants
OBSERVATIONAL
2018-07-02
2021-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objectives are:
* To examine the feasibility of screening subjects of ≥65 years old for AAF.
* To validate the smartphone connected MED as an AAF screening instrument for application in transmural care in the Netherlands.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Systematic ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm and Halland, Sweden
NCT01593553
Atrial Fibrillation Screening With a Smartphone Device and iECG Application
NCT02534532
DeteCtiON and Stroke PreventIon by MoDEl ScRreenING for Atrial Fibrillation
NCT05838781
Improving DEtection of Atrial fibriLlation in Primary Care With the MyDiagnostick
NCT02270151
Atrial Fibrillation Screening Post Ischemic Cerebrovascular Events
NCT05134454
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Prospective validation study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Screening with Mobile ECG Device
Subjects with asymptomatic atrial fibrillation will be screened by using a Mobile ECG Device
Subjects with asymptomatic atrial fibrillation will be screened by using a Mobile ECG Device
Subjects with asymptomatic atrial fibrillation will be screened by using a Mobile ECG Device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Subjects with asymptomatic atrial fibrillation will be screened by using a Mobile ECG Device
Subjects with asymptomatic atrial fibrillation will be screened by using a Mobile ECG Device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Is willing to give informed consent
Exclusion Criteria
* Not mental competent
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Diagram B.V.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Isala
Zwolle, Overijssel, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9275
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.